Memory loss and drugs of ingredients of danazol (a real world drug study)
Summary:
Memory loss is found among people who take drugs with ingredients of danazol, especially for people who are female, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 3,774 people who have side effects when taking drugs with ingredients of danazol from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Danazol, Danocrine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
3,774 people reported to have side effects when taking drugs with ingredients of danazol.
Among them, 46 people (1.22%) have Memory loss
What is Memory loss?
Memory loss is found to be associated with 2,726 drugs and 4,377 conditions by eHealthMe. Check the latest studies of Memory loss.
Number of reports submitted per year:

Gender of people who have Memory loss when taking drugs with ingredients of danazol *:
- female: 78.12 %
- male: 21.88 %
Age of people who have Memory loss when taking drugs with ingredients of danazol *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 6.9 %
- 30-39: 6.9 %
- 40-49: 13.79 %
- 50-59: 31.03 %
- 60+: 41.38 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Primary Myelofibrosis (primary disorder of the bone marrow): 13 people, 28.26%
- Itching: 6 people, 13.04%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 13.04%
- High Blood Pressure: 3 people, 6.52%
- Immune System Disorder: 2 people, 4.35%
- Muscle Spasms (muscle contraction): 2 people, 4.35%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 4.35%
- Ill-Defined Disorder: 2 people, 4.35%
- Sleep Disorder: 2 people, 4.35%
- Depression: 2 people, 4.35%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Jakafi: 13 people, 28.26%
- Lipitor: 9 people, 19.57%
- Metformin: 7 people, 15.22%
- Vitamin D: 7 people, 15.22%
- Glucophage: 7 people, 15.22%
- Ondansetron: 6 people, 13.04%
- Dilaudid: 6 people, 13.04%
- Insulin: 6 people, 13.04%
- Calcium: 6 people, 13.04%
- Levemir: 6 people, 13.04%
Other side effects people have besides Memory loss *:
You may use this to check any potential undetected side effects.
- Fatigue (feeling of tiredness): 23 people, 50.00%
- Thrombocytopenia (decrease of platelets in blood): 15 people, 32.61%
- Head Injury: 13 people, 28.26%
- Fall: 12 people, 26.09%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 23.91%
- Night Sweats (sweating in night): 10 people, 21.74%
- Malaise (a feeling of general discomfort or uneasiness): 10 people, 21.74%
- Gait Disturbance: 10 people, 21.74%
- Weakness: 10 people, 21.74%
- Nausea (feeling of having an urge to vomit): 10 people, 21.74%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of danazol, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on danazol. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gallbladder Disease and drugs of ingredients of sunitinib malate - 3 seconds ago
- Abscess Jaw and drugs of ingredients of docetaxel - 5 seconds ago
- Revlimid and Reglan drug interactions for women aged 60+ - 5 seconds ago
- How effective is Arava for Arthritis? - 6 seconds ago
- Joint Range Of Motion Decreased and drugs of ingredients of melphalan hydrochloride - 7 seconds ago
- Tranxene and Isosorbide Mononitrate drug interactions for women aged 60+ - 10 seconds ago
- Laryngitis and drugs of ingredients of lenvatinib mesylate - 10 seconds ago
- Drug interactions of Nuvigil and Ondansetron - 11 seconds ago
- Drug interactions of Carafate and Multivitamin - 11 seconds ago
- Rickets and drugs of ingredients of levetiracetam - 12 seconds ago